文献速递重症综合管理与镇静镇痛儿科与产科急症

儿童血小板减少症病因与预后:10年儿科重症监护病房683例分析

[Etiology and prognosis of thrombocytopenia in children: a case analysis in 683 children within 10 years of pediatric intensive care unit].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2018-01-01
一句话结论PICU血小板减少症发生率10.2%,非血液恶性肿瘤相关占73.9%,血液恶性肿瘤相关病死率24.7%,年龄越小、PLT越低预后越差。

该回顾性研究分析2008年1月至2017年12月安徽省儿童医院PICU收治的683例血小板减少症(TP)患儿,占同期PICU住院6725例的10.2%。非血液恶性肿瘤相关TP占73.9%(病死率11.1%),血液恶性肿瘤相关TP占21.4%(病死率24.7%),假性血小板减少占0.6%(病死率0%)。婴儿组病死率18.8%显著高于幼儿组14.0%、学龄前组6.7%、学龄组4.3%及青春期组0%(均P<0.01);PLT≤20×10^9/L组病死率18.1%显著高于PLT(21-50)×10^9/L组13.0%和PLT>(50-100)×10^9/L组9.5%(均P<0.05)。结论认为MODS、感染、脓毒症、严重创伤和DIC是PICU中TP的常见原因,年龄越小、PLT越低预后越差。

要点

  • PICU中TP发生率为10.2%(683/6725),总病死率13.5%(92/683)。
  • 血液恶性肿瘤相关TP病死率24.7%(36/146),显著高于非血液恶性肿瘤相关TP的11.1%(56/505)。
  • 非血液恶性肿瘤相关TP中,MODS占26.9%(病死率15.4%),DIC病死率24.1%(14/58),中枢神经系统感染病死率20.3%(12/59)。
  • 婴儿组TP病死率18.8%(53/282)显著高于幼儿组14.0%、学龄前组6.7%、学龄组4.3%及青春期组0%(均P<0.01)。
  • PLT≤20×10^9/L组病死率18.1%(39/215)显著高于PLT(21-50)×10^9/L组13.0%和PLT>(50-100)×10^9/L组9.5%(均P<0.05)。

适用人群与场景

  • 2008年1月至2017年12月安徽省儿童医院PICU收治的683例血小板减少症患儿,排除先天性和不明原因TP。
  • 按年龄分为婴儿组(29天至<1岁)、幼儿组(1至<3岁)、学龄前组(3至<6岁)、学龄组(6至<10岁)和青春期组(>10岁)。
  • 按最低血小板计数分为PLT≤20×10^9/L组、PLT(21-50)×10^9/L组和PLT>(50-100)×10^9/L组。

研究设计与关键结果

  • 回顾性分析683例PICU血小板减少症患儿,占同期PICU住院6725例的10.2%,男387例、女296例,中位年龄2.72(0.61,3.08)岁,死亡92例,总病死率13.5%。
  • 非血液恶性肿瘤相关TP占73.9%(505/683),病死率11.1%(56/505);血液恶性肿瘤相关TP占21.4%(146/683),病死率24.7%(36/146);假性血小板减少占0.6%(4/683),病死率0%(0/4);放弃治疗者占4.1%。
  • 非血液恶性肿瘤相关TP中,MODS占26.9%(136/505),病死率15.4%(21/136);脓毒症占17.4%(88/505),病死率8.0%(7/88);严重创伤占16.6%(84/505),病死率2.4%(2/84);肺炎占12.7%(64/505),病死率0%(0/64);中枢神经系统感染占11.7%(59/505),病死率20.3%(12/59);DIC占11.5%(58/505),病死率24.1%(14/58)。
  • 血液恶性肿瘤相关TP主要病因为噬血细胞综合征(占27.4%,病死率32.5%,13/40)和骨髓抑制(占21.2%,病死率25.8%,8/31)。
  • 婴儿组病死率18.8%(53/282)显著高于幼儿组14.0%(28/200)、学龄前组6.7%(7/104)、学龄组4.3%(4/92)和青春期组0%(0/5),均P<0.01。
  • PLT≤20×10^9/L组病死率18.1%(39/215)显著高于PLT(21-50)×10^9/L组13.0%(32/247)和PLT>(50-100)×10^9/L组9.5%(21/221),均P<0.05。
  • 年龄与28天死亡时间无关联(r=-0.037,P=0.727),PLT与28天死亡时间呈正相关(r=0.844,P=0.010)。

证据类型、等级与局限

  • 证据类型:单中心回顾性病例分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为MODS、感染、脓毒症、严重创伤和DIC是PICU中血小板减少症的常见原因。
  • 作者认为血小板减少症患儿年龄越小、PLT越低,预后越差。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To analyze the etiology and prognosis of children with thrombocytopenia (TP) in pediatric intensive care unit (PICU).

METHODS: The data of children with TP (exclusion of congenital and unknown TP) admitted to PICU of Anhui Provincial Children's Hospital from January 2008 to December 2017 was analyzed retrospectively. According to the age of onset, the children were divided into infantile group (29 days to less than 1 year), early childhood group (1 to less than 3 years), preschool group (3 to less than 6 years), school age group (6 to less than 10 years) and puberty group (more than 10 years). Moreover, according to the lowest platelet count (PLT), the children were divided into PLT ≤ 20×109/L group, PLT (21-50)×109/L group and PLT > (50-100) ×109/L group. The distribution and mortality of TP were analyzed, and the relationship between age, PLT decrease and prognosis were analyzed by Pearson method.

RESULTS: Among 6 725 children admitted to PICU in our hospital from January 2008 to December 2017, there were 683 children with TP, with the incidence of 10.2%. Among 683 children with TP, there were 387 males and 296 females, with the median age of 2.72 (0.61, 3.08) years, and 92 children died, with a total mortality of 13.5%. Analysis of primary disease showed that TP caused by non-hematological malignant tumor disease accounted for 73.9%, with the mortality of 11.1% (56/505). TP induced by hematological malignant tumor disease accounted for 21.4%, with the mortality of 24.7% (36/146). Pseudothrombocytopenia accounted for 0.6%, with the mortality of 0% (0/4). Other children who gave up treatment accounted for 4.1%. It was shown by further analysis that multiple organ dysfunction syndrome (MODS) caused by TP associated with non-hematological malignant tumor disease accounted for 26.9%, with the mortality of 15.4% (21/136). Sepsis, severe trauma, pneumonia, central nervous system infection and disseminated intravascular coagulation (DIC) accounted for 17.4%, 16.6%, 12.7%, 11.7% and 11.5%; with the mortality of 8.0% (7/88), 2.4% (2/84), 0% (0/64), 20.3% (12/59) and 24.1% (14/58), respectively. The main causes of TP associated with hematological malignant tumor disease were hemophagocytic syndrome [accounting for 27.4%, with the mortality of 32.5% (13/40)] and bone marrow inhibition [accounting for 21.2%, with the mortality of 25.8% (8/31)]. The younger were the children with TP, the higher would be the mortality. The mortality of infantile group was significantly higher than that of early childhood group, preschool group, school age group and puberty group [18.8% (53/282) vs. 14.0% (28/200), 6.7% (7/104), 4.3% (4/92), 0% (0/5), all P < 0.01]. The lower was the PLT, the higher would be the mortality. The mortality of PLT ≤ 20×109/L group was significantly higher than that of PLT (21-50)×109/L group and PLT > (50-100)×109/L group [18.1% (39/215) vs. 13.0% (32/247), 9.5% (21/221), both P < 0.05]. It was shown by correlation analysis that there was no association between age and 28-day death time in children with TP (r = -0.037, P = 0.727), but PLT was positively correlated with 28-day death time in children with TP (r = 0.844, P = 0.010).

CONCLUSIONS: MODS, infection, sepsis, severe trauma and DIC are the common causes of TP in PICU. The younger are the children with TP, the lower is the PLT, and the worse would be the prognosis.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Xu Y, Jin D, Tong W, et al. [Etiology and prognosis of thrombocytopenia in children: a case analysis in 683 children within 10 years of pediatric intensive care unit]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 30439319. doi:10.3760/cma.j.issn.2095-4352.2018.010.013

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。